I think being part of M/A is very likely. The larger potential suitors in the medical device industry will not be able to pass up this opportunity. Further, to Lefty's points earlier - I think there are more possible suitors than previously thought that could view Titan as a new acquision for the following reasons:
1) I would like to suggest global companies like GE, Samsung, Canon, or Seimens as possible suitors. They all have deep pockets, long-term business models, and medical divisions.
2) Paranoia. Buy the company or your competitors will.
3) Possible tax benefits, and executives love a good acquisition to justify their existence and prove they're worthy as BIG thinkers.
4) Buy the company, because licensing the IP still requires a big investment to develop the product. R&D is an industry in and of itself. Time is money. If you have the money to address an issue or problem then spend the money. It's better than letting it sit.
5) Buy the company because it's easier to manage a tangible product than a multifaceted project. Stay focused on the core business.
6) Why now? Timing. The market was not big or mature enough previously to justify the cost to buy out Titan. The pie is, and will continue to get bigger.
Food for thought.
IMO
News 
Market Data 
Discover 
AI
